The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Key Concepts of Clinical Trials: A Narrative Review
Open accessAbstract
The recent focus of federal funding on comparative effectiveness research underscores the importance of clinical trials in the practice of evidence-based medicine and health care reform. The impact of clinical trials not only extends to the individual patient by establishing a broader selection of effective therapies, but also to society as a whole by enhancing the value of health care provided. However, clinical trials also have the potential to pose unknown risks to their participants, and biased knowledge extracted from flawed clinical trials may lead to the inadvertent harm of patients. Although conducting a well-designed clinical trial may appear straightforward, it is founded on rigorous methodology and oversight governed by key ethical principles. In this review, we provide an overview of the ethical foundations of trial design, trial oversight, and the process of obtaining approval of a therapeutic, from its pre-clinical phase to post-marketing surveillance. This narrative review is based on a course in clinical trials developed by one of the authors (DJM), and is supplemented by a PubMed search predating January 2011 using the keywords "randomized controlled trial," "patient/clinical research," "ethics," "phase IV," "data and safety monitoring board," and "surrogate endpoint." With an understanding of the key principles in designing and implementing clinical trials, health care providers can partner with the pharmaceutical industry and regulatory bodies to effectively compare medical therapies and thereby meet one of the essential goals of health care reform.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · BMJ · doi:10.1136/bmj.c332 · Cited by 9,329
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
(2003) · Manual for Research Ethics Committees · doi:10.1017/cbo9780511550089.028 · Cited by 3,413
Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241201 · Cited by 3,253
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · BMC Medical Research Methodology · doi:10.1186/1471-2288-1-2 · Cited by 2,755
Moher, D. (2001) · JAMA · doi:10.1001/jama.285.15.1987 · Cited by 2,545
Equipoise and the Ethics of Clinical Research
Freedman, B. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707163170304 · Cited by 2,339
Surrogate endpoints in clinical trials: Definition and operational criteria
Prentice, R. L. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080407 · Cited by 2,057
Surrogate End Points in Clinical Trials: Are We Being Misled?
Fleming, T. R., & DeMets, D. L. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00011 · Cited by 1,651
Timing of new black box warnings and withdrawals for prescription medications
Lasser, K. E. (2002) · JAMA · doi:10.1001/jama.287.17.2215 · Cited by 1,005
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
James, W. P. T., Caterson, I. D., Coutinho, W., Finer, N., Van Gaal, L. F., Maggioni, A. P., Torp-Pedersen, C., Sharma, A. M., Shepherd, G. M., Rode, R. A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003114 · Cited by 943
Racism and Research: The Case of the Tuskegee Syphilis Study
Brandt, A. M. (1978) · The Hastings Center Report · doi:10.2307/3561468 · Cited by 848
A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease
The International Chronic Granulomatous Disease Cooperative Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199102213240801 · Cited by 830
Understanding Equivalence and Noninferiority Testing
Walker, E., & Nowacki, A. S. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1513-8 · Cited by 751
Research Methods in the Behavioral Sciences
Blankertz, D. F., Festinger, L., & Katz, D. (1954) · Journal of Marketing · doi:10.2307/1247742 · Cited by 708
Quality of informed consent in cancer clinical trials: a cross-sectional survey
Joffe, S., Cook, E. F., Cleary, P. D., Clark, J. W., & Weeks, J. C. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06805-2 · Cited by 655
The method of minimization for allocation to clinical trials
Scott, N. W., McPherson, G. C., Ramsay, C. R., & Campbell, M. K. (2002) · Controlled Clinical Trials · doi:10.1016/s0197-2456(02)00242-8 · Cited by 651 · cited 1×
“allocation, designed to reduce imbalances among multiple strata and study arms.(34)”
BackgroundWhat's the Price of a Research Subject? Approaches to Payment for Research Participation
Dickert, N., & Grady, C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907153410312 · Cited by 465
Strategies to improve recruitment to randomised controlled trials
Treweek, S., Mitchell, E., Pitkethly, M., Cook, J., Kjeldstrøm, M., Johansen, M., Taskila, T. K., Sullivan, F., Wilson, S., Jackson, C., et al. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000013.pub5 · Cited by 378
Are Surrogate Markers Adequate to Assess Cardiovascular Disease Drugs?
Temple, R. (1999) · JAMA · doi:10.1001/jama.282.8.790 · Cited by 337
Probability of adverse events that have not yet occurred: a statistical reminder
Eypasch, E., Lefering, R., Kum, C. K., & Troidl, H. (1995) · BMJ · doi:10.1136/bmj.311.7005.619 · Cited by 336
Trends in the Risks and Benefits to Patients With Cancer Participating in Phase 1 Clinical Trials
Roberts, T. G. (2004) · JAMA · doi:10.1001/jama.292.17.2130 · Cited by 319
Biomarkers and surrogate end points—the challenge of statistical validation
Buyse, M., Sargent, D. J., Grothey, A., Matheson, A., & de Gramont, A. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.43 · Cited by 314
Data Monitoring Committees in Clinical Trials
Ellenberg, S. S., Fleming, T. R., & DeMets, D. L. (2002) · Wiley eBooks · doi:10.1002/0470854162 · Cited by 268
The Need to Revise the Declaration of Helsinki
Levine, R. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410713 · Cited by 262
Medical Ethics and Controlled Trials
Hill, A. B. (1963) · BMJ · doi:10.1136/bmj.1.5337.1043 · Cited by 261
Postmarketing Surveillance—Lack of Vigilance, Lack of Trust
Fontanarosa, P. B. (2004) · JAMA · doi:10.1001/jama.292.21.2647 · Cited by 221
Current issues in non‐inferiority trials
Fleming, T. R. (2008) · Statistics in Medicine · doi:10.1002/sim.2855 · Cited by 211
Bakke, O. M., Manocchia, M., de Abajo, F., Kaitin, K. I., & Lasagna, L. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90078-0 · Cited by 208
Strategies to improve recruitment to research studies
Mapstone, J., Elbourne, D., & Roberts, I. G. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000013.pub3 · Cited by 196
Protecting Research Subjects — The Crisis at Johns Hopkins
Steinbrook, R. (2002) · New England Journal of Medicine · doi:10.1056/nejm200202283460924 · Cited by 169
Design of a National Distributed Health Data Network
Maro, J. C., Platt, R., Holmes, J. H., Strom, B. L., Hennessy, S., Lazarus, R., & Brown, J. S. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-5-200909010-00139 · Cited by 165
Hennekens, C. H. (2009) · JAMA · doi:10.1001/jama.2009.1756 · Cited by 149
Sir Austin Bradford Hill and the progress of medical science.
Doll, R. (1992) · BMJ · doi:10.1136/bmj.305.6868.1521 · Cited by 112
A Duty to Deceive: Placebos in Clinical Practice
Foddy, B. (2009) · The American Journal of Bioethics · doi:10.1080/15265160903318350 · Cited by 108
The Role of Meta-analysis in the Regulatory Process for Foods, Drugs, and Devices
Berlin, J. A., & Colditz, G. A. (1999) · JAMA · doi:10.1001/jama.281.9.830 · Cited by 100
The Rise of Litigation in Human Subjects Research
Mello, M. M., Studdert, D. M., & Brennan, T. A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-1-200307010-00011 · Cited by 81
Helsinki Discord? A Controversial Declaration
Vastag, B. (2000) · JAMA · doi:10.1001/jama.284.23.2983 · Cited by 63
Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions
Strom, B. L. (2004) · JAMA · doi:10.1001/jama.292.21.2643 · Cited by 59
Drug Withdrawals in the United States: A Systematic Review of the Evidence and Analysis of Trends
Issa, A. M., Phillips, K., Bebber, S. L. V., et al. (2007) · Current Drug Safety · doi:10.2174/157488607781668855 · Cited by 59
Evaluation of informed consent in health research: a questionnaire survey
Länsimies‐Antikainen, H., Laitinen, T. P., Rauramaa, R., & Pietilä, A. (2009) · Scandinavian Journal of Caring Sciences · doi:10.1111/j.1471-6712.2008.00684.x · Cited by 25
Cahana, A., & Romagnioli, S. (2007) · Journal of Anesthesia · doi:10.1007/s00540-006-0440-7 · Cited by 21
Looking at Research Consent Forms through a Participant-Centered Lens: The PRISM Readability Toolkit
Ridpath, J. R., Wiese, C. J., & Greene, S. M. (2009) · American Journal of Health Promotion · doi:10.4278/ajhp.080613-cit-94 · Cited by 19
Methodological issues in AIDS clinical trials. Intent-to-treat analysis.
Tsiatis, A. A. (1990) · PubMed · Cited by 10
Research works printed but not linked: 7
- . Trials of War Criminals Before the Nuremberg Military Tribunals Under Control Council Law. No. 10, Vol. 2. Washington, DC: US Government Printing Office; 1949:181–182
- World Medical Organization, 1996, BMJ., 1996, 1448
- International Conference on Harmonisation, 1994, Good clinical practice guidelines for essential documents for the conduct of a clinical trial
- Wilcox CM, 2008, Gastrointest Endosc., 67, 123, 10.1016/j.gie.2007.09.003 · doi:10.1016/j.gie.2007.09.003
- Tsiatis A, 1990, J Acquir Immune Defic Syndr., 3, S120
- 2010, AERS patient outcomes by year
- Guidance for Industry, 1996, E6. Good clinical practice—consolidated guidance
Cited by
Baxi, S., Yang, A., Gennarelli, R. L., Khan, N., Wang, Z., Boyce, L., & Korenstein, D. (2018) · BMJ · doi:10.1136/bmj.k793 · Cited by 578
Cohen, S. P., Bhaskar, A., Bhatia, A., Buvanendran, A., Deer, T., Garg, S., Hooten, W. M., Hurley, R. W., Kennedy, D. J., McLean, B. C., et al. (2020) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2019-101243 · Cited by 371
Metallodrugs in cancer nanomedicine
Peña, Q., Wang, A., Zaremba, O., Shi, Y., Scheeren, H. W., Metselaar, J. M., Kiessling, F., Pallares, R. M., Wuttke, S., & Lammers, T. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00468a · Cited by 259
Larson, D. B., Harvey, H., Rubin, D. L., Irani, N., Tse, J. R., & Langlotz, C. P. (2021) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2020.09.060 · Cited by 198
Cummings, J., Ritter, A., & Zhong, K. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179901 · Cited by 176
Metadata
- Authors
- Umscheid, C. A., Margolis, D. J., & Grossman, C. E.
- Venue
- Postgraduate Medicine
- Publisher
- Informa UK Limited
- Published
- 2011-09
- Volume
- 123
- Issue
- 5
- Pages
- 194-204
- ISSN
- 0032-5481 (ISSN-L)
- 1941-9260
- OpenAlex
- W2000082121
- Cited by
- 410
- References
- 47
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.